In this study, we observed comparably strong associations between plasma p-tau217 and tau-PET with cognitive decline on a sensitive global cognitive composite test (that is, mPACC5) and with clinical progression to MCI in CU individuals. The gene discussed is MAPT; the disease is Mental deterioration.